Psyence Group Presenting at Canaccord Genuity ConferenceArticles@nasdaq/psyence-group-presenting-at-canaccord-genuity-conference channel 1 online Today This week by @nasdaq on 3 Feb 2021, 18:15 Psyence Group Presenting at Canaccord Genuity Conference "New Paradigms & Treatment Approaches in Mental Health" TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (Psyence or the Company) is pleased to announce that its Co-founder and CEO, Jody Aufrichtig will be presenting at the Canaccord Genuity conference "New Paradigms & Treatment Approaches in Mental Health", being held tomorrow, February 4, 2021 at 9am EST. Direct Webcast Link: https://wsw.com/webcast/canaccord50/psy/2291892 Psyence Group is pioneering the use of natural psilocybin for the long-term treatment of trauma and its mental health consequences. The Companys global footprint operates across multiple legal jurisdictions, through the advanced provision of psychedelic therapy and experience, as well as market leading functional mushroom brands and product portfolio.